Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients

BACKGROUND: The effectiveness of the best combination between different antiviral and anti-inflammatory drugs stills an interest in the treatment of COVID19 infection. PATIENTS AND METHODS: A prospective randomized cohort study comprised 108 adult patients with confirmed PCR COVID 19 infection with...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarhan, Rania M., Harb, Hadeer S., Abou Warda, Ahmed E., Salem-Bekhit, Mounir M., Shakeel, Faiyaz, Alzahrani, Sami Ali, Madney, Yasmin M., Boshra, Marian S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562044/
https://www.ncbi.nlm.nih.gov/pubmed/34764044
http://dx.doi.org/10.1016/j.jiph.2021.10.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562044/
https://www.ncbi.nlm.nih.gov/pubmed/34764044
http://dx.doi.org/10.1016/j.jiph.2021.10.024

Ejemplares similares